Pembrolizumab combined with induction chemotherapy and radiotherapy has good clinical efficacy in patients with intermediate and advanced lung squamous cell carcinoma

Xinying WANG; Jiashu LI; Weiquan JIN; Yuhai GU

doi:10.12122/j.issn.1674-4500.2022.04.05

中国科技核心期刊（中国科技论文统计源期刊）
《中国学术期刊（光盘版）》收录期刊
《中国核心期刊（遴选）数据库》收录期刊
中国学术期刊综合评价数据库（CAJCED）统计源期刊
美国《乌利希期刊指南》（Ulrichsweb）来源期刊

Journal of Molecular Imaging ›› 2022, Vol. 45 ›› Issue (4) : 486-492. DOI: 10.12122/j.issn.1674-4500.2022.04.05

Pembrolizumab combined with induction chemotherapy and radiotherapy has good clinical efficacy in patients with intermediate and advanced lung squamous cell carcinoma

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2022, 45(4): 486-492 https://doi.org/10.12122/j.issn.1674-4500.2022.04.05

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

Funding

RIGHTS & PERMISSIONS

PDF(1574 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2022-05-10	2022-07-20
Issue Date
2024-12-20

Please choose a citation manager

Content to export

HeighLight

Abstract

Key words

Cite this article

{{custom_sec.title}}

{{custom_sec.title}}

References

References

{{custom_fnGroup.title_en}}

Footnotes

{{custom_ack.title_en}}

Funding

RIGHTS & PERMISSIONS